The rally is being fuelled by solid quarterly results and a string of optimistic fiscal 2026 outlooks from leading drugmakers ...

With the stock's price at Rs 3222.50, Torrent Pharmaceuticals' performance reflects its position in the pharmaceutical sector.

Shares of ONGC, IndiGo, IndusInd Bank, and RVNL are expected to be in the spotlight today as these companies are set to ...

Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong ...

Jefferies recommends Buy on DLF, CMS Info Systems, and Torrent Pharma, citing strong fundamentals and growth prospects. Check ...

Mumbai: Torrent Pharmaceuticals on Wednesday reported a 0.99 per cent quarter-on-quarter (QoQ) decline in its net profit for the fourth quarter (Q4) of FY25, with earnings dropping to Rs 498 crore ...

Torrent Pharmaceuticals added 1.53% to Rs 3,292.95 after the company's consolidated net profit increased 10.91% to Rs 498 crore in Q4 FY25 as against Rs 449 crore posted in Q4 FY24.

Torrent Pharmaceuticals posted a steady set of numbers in the fourth quarter, reinforcing confidence in its growth trajectory ...

On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

Net Sales at Rs 2,433.00 crore in March 2025 up 13.53% from Rs. 2,143.00 crore in March 2024. Quarterly Net Profit at Rs. 474.00 crore in March 2025 up 15.61% from Rs. 410.00 crore in March 2024.